Chemometec A/S
CSE:CHEMM

Watchlist Manager
Chemometec A/S Logo
Chemometec A/S
CSE:CHEMM
Watchlist
Price: 472.4 DKK 4.47% Market Closed
Market Cap: 8.2B DKK
Have any thoughts about
Chemometec A/S?
Write Note

Chemometec A/S
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chemometec A/S
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Chemometec A/S
CSE:CHEMM
Revenue
kr407.9m
CAGR 3-Years
13%
CAGR 5-Years
18%
CAGR 10-Years
N/A
G
Gubra A/S
CSE:GUBRA
Revenue
kr205m
CAGR 3-Years
6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Chemometec A/S
Glance View

Market Cap
8.2B DKK
Industry
Life Sciences Tools & Services

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for fluid cell count and analysis. The Company’s activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Company’s analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.

CHEMM Intrinsic Value
262.27 DKK
Overvaluation 44%
Intrinsic Value
Price

See Also

What is Chemometec A/S's Revenue?
Revenue
407.9m DKK

Based on the financial report for Jun 30, 2024, Chemometec A/S's Revenue amounts to 407.9m DKK.

What is Chemometec A/S's Revenue growth rate?
Revenue CAGR 5Y
18%

Over the last year, the Revenue growth was -8%. The average annual Revenue growth rates for Chemometec A/S have been 13% over the past three years , 18% over the past five years .

Back to Top